Literature DB >> 9111814

Tea consumption and cancer.

S K Katiyar1, H Mukhtar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9111814

Source DB:  PubMed          Journal:  World Rev Nutr Diet        ISSN: 0084-2230            Impact factor:   0.575


× No keyword cloud information.
  17 in total

Review 1.  The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review.

Authors:  Maurice P A Zeegers; Eliane Kellen; Frank Buntinx; Piet A van den Brandt
Journal:  World J Urol       Date:  2003-12-17       Impact factor: 4.226

Review 2.  Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components.

Authors:  Y Li; T O Tollefsbol
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

3.  Tea drinking and the risk of biliary tract cancers and biliary stones: a population-based case-control study in Shanghai, China.

Authors:  Xue-Hong Zhang; Gabriella Andreotti; Yu-Tang Gao; Jie Deng; Enju Liu; Asif Rashid; Kai Wu; Lu Sun; Lori C Sakoda; Jia-Rong Cheng; Ming-Chang Shen; Bing-Sheng Wang; Tian-Quan Han; Bai-He Zhang; Gloria Gridley; Joseph F Fraumeni; Ann W Hsing
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

Review 4.  Epigenetic cancer prevention mechanisms in skin cancer.

Authors:  Kamalika Saha; Thomas J Hornyak; Richard L Eckert
Journal:  AAPS J       Date:  2013-08-01       Impact factor: 4.009

Review 5.  Pharmacokinetic and chemoprevention studies on tea in humans.

Authors:  H-H Sherry Chow; Iman A Hakim
Journal:  Pharmacol Res       Date:  2011-05-20       Impact factor: 7.658

6.  (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells.

Authors:  Vijayalakshmi Nandakumar; Mudit Vaid; Santosh K Katiyar
Journal:  Carcinogenesis       Date:  2011-01-05       Impact factor: 4.944

Review 7.  Disease-modifying therapies for osteoarthritis : current status.

Authors:  Marc Fajardo; Paul E Di Cesare
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

8.  A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers.

Authors:  Jason R Gee; Daniel R Saltzstein; KyungMann Kim; Jill Kolesar; Wei Huang; Thomas C Havighurst; Barbara W Wollmer; Jeanne Stublaski; Tracy Downs; Hasan Mukhtar; Margaret G House; Howard L Parnes; Howard H Bailey
Journal:  Cancer Prev Res (Phila)       Date:  2017-03-21

9.  The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression.

Authors:  Anping Chen; Li Zhang; Jianye Xu; Jun Tang
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

10.  EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase.

Authors:  Thejass Punathil; Trygve O Tollefsbol; Santosh K Katiyar
Journal:  Biochem Biophys Res Commun       Date:  2008-08-08       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.